NL7311000A - - Google Patents

Info

Publication number
NL7311000A
NL7311000A NL7311000A NL7311000A NL7311000A NL 7311000 A NL7311000 A NL 7311000A NL 7311000 A NL7311000 A NL 7311000A NL 7311000 A NL7311000 A NL 7311000A NL 7311000 A NL7311000 A NL 7311000A
Authority
NL
Netherlands
Application number
NL7311000A
Other versions
NL162641B (nl
NL162641C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7311000A publication Critical patent/NL7311000A/xx
Publication of NL162641B publication Critical patent/NL162641B/xx
Application granted granted Critical
Publication of NL162641C publication Critical patent/NL162641C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02Disazo dyes
    • C09B31/12Disazo dyes from other coupling components "C"
    • C09B31/14Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7311000.A 1972-08-12 1973-08-09 Werkwijze ter bereiding van een farmaceutisch preparaat op basis van een in de benzeenkern gesubstitueerde 4-(heterocyclosulfonyl)-benzeensulfonamide, aldus ver- vaardigde gevormde farmaceutische preparaten, en werk- wijze ter bereiding van in de benzeenkern gesubstitueer- de 4-(heterocyclosulfonyl)-benzeensulfonamiden. NL162641C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (3)

Publication Number Publication Date
NL7311000A true NL7311000A (enExample) 1974-02-14
NL162641B NL162641B (nl) 1980-01-15
NL162641C NL162641C (nl) 1980-06-16

Family

ID=10398552

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7311000.A NL162641C (nl) 1972-08-12 1973-08-09 Werkwijze ter bereiding van een farmaceutisch preparaat op basis van een in de benzeenkern gesubstitueerde 4-(heterocyclosulfonyl)-benzeensulfonamide, aldus ver- vaardigde gevormde farmaceutische preparaten, en werk- wijze ter bereiding van in de benzeenkern gesubstitueer- de 4-(heterocyclosulfonyl)-benzeensulfonamiden.

Country Status (16)

Country Link
US (1) US3867390A (enExample)
JP (2) JPS59508B2 (enExample)
AT (1) AT331248B (enExample)
AU (1) AU5908473A (enExample)
BE (1) BE803373A (enExample)
CA (1) CA978945A (enExample)
DE (1) DE2340010A1 (enExample)
ES (1) ES417806A1 (enExample)
FR (1) FR2195449B1 (enExample)
GB (1) GB1380009A (enExample)
IE (1) IE38177B1 (enExample)
IN (1) IN139006B (enExample)
LU (1) LU68211A1 (enExample)
NL (1) NL162641C (enExample)
SE (1) SE385008B (enExample)
ZA (1) ZA735474B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Also Published As

Publication number Publication date
US3867390A (en) 1975-02-18
AT331248B (de) 1976-08-10
IE38177L (en) 1974-02-12
JPS4985066A (enExample) 1974-08-15
JPS5857431B2 (ja) 1983-12-20
NL162641B (nl) 1980-01-15
IE38177B1 (en) 1978-01-18
LU68211A1 (enExample) 1975-05-21
CA978945A (en) 1975-12-02
GB1380009A (en) 1975-01-08
IN139006B (enExample) 1976-04-24
JPS59508B2 (ja) 1984-01-07
SE385008B (sv) 1976-05-31
BE803373A (fr) 1974-02-08
ATA691573A (de) 1975-11-15
AU5908473A (en) 1975-02-13
FR2195449B1 (enExample) 1977-09-09
ZA735474B (en) 1974-08-28
FR2195449A1 (enExample) 1974-03-08
DE2340010A1 (de) 1974-03-14
JPS57131774A (en) 1982-08-14
ES417806A1 (es) 1976-03-01
NL162641C (nl) 1980-06-16

Similar Documents

Publication Publication Date Title
JPS4944849A (enExample)
FR2191377B1 (enExample)
FR2195094B1 (enExample)
JPS4987393A (enExample)
JPS4985066A (enExample)
FR2194082A1 (enExample)
FR2190752B1 (enExample)
JPS5214993B2 (enExample)
JPS4927264A (enExample)
JPS5232499Y2 (enExample)
JPS525269B2 (enExample)
JPS4972897U (enExample)
JPS4962375A (enExample)
JPS49124233A (enExample)
JPS4933566U (enExample)
CH586513A5 (enExample)
CH571797A5 (enExample)
CH563551A5 (enExample)
CH564354A5 (enExample)
NL7301530A (enExample)
SE7205039L (enExample)
CH586713A5 (enExample)
CH584308A5 (enExample)
CH582160A5 (enExample)
CH580681A5 (enExample)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee